Mark J. Vignola, Chief Financial Officer at Terns Pharmaceuticals, Inc. (TERN), bought 7,656 shares at $1.47 ($11K) on 2022-05-31, disclosed to the SEC on 2022-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TERN | BUY | 2024-06-04 | $21K | — | Filing → |
| TERN | BUY | 2023-12-04 | $3K | — | Filing → |
| TERN | BUY | 2023-06-02 | $14K | — | Filing → |